Meitheal Pharmaceuticals will commercialize the U.S. rollout of newly FDA-approved Garzulys, an insulin biosimilar to Novolog, broadening its biologics and branded products business.
Recommended For You
-
Consumer Products
Alcohol distributor Republic National cutting nearly 300 jobs in Illinois
Republic National filed for Chapter 11 bankruptcy protection over the weekend and plans to shut down operations in Niles and Romeoville.
-
Politics & Policy
Johnson loses budget director days after CFO exit
Interim-CFO Steven Mahr left his position last week.
-
Commentary
Opinion: Reduction at CSX’s South Side Barr Yard is a signal switch that can’t be ignored
Facilities like Barr Yard are essential infrastructure that strengthens the national rail network, not simply as costs to be reduced.
-
Health Care
U.S. hospital sector to see K-shaped path with federal cuts expected
After years of gradual improvement, “the tone for the sector has turned more cautious.”
-
Commercial Real Estate
Palmer House retail space hitting the auction block
LNR Partners is seeking to sell the retail space at the base of the Palmer House Hilton hotel in an auction next week, after taking over the property in 2023.
-
Politics & Policy
Push to sideline Johnson from picking new police chief draws mixed response
The commission overseeing the search is currently scheduled to send Mayor Brandon Johnson three finalists by Nov. 12.
-
Daily Gist
Latest sign of Mag Mile’s value reset: Crain’s Daily Gist podcast
A Chicago investor got a discount for Palmolive Building retail space in a deal that illustrates the Mag Mile’s fallen property values.